8-K2.029.01
8-K exhibit
EDGARCoya Therapeutics, Inc. Common Stock
Coya Therapeutics, Inc. Common Stock (COYA) SEC filings
Coya Therapeutics, Inc. Common Stock (COYA) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported COYA revenue for 2025-09-30 was $3.6M. Net income was -$15.5M. Revenue was up 2078.4% from 2025-06-30 to 2025-09-30. COYA currently screens at market cap $118.0M. The COYA filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Coya Therapeutics, Inc. Common Stock said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
4
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all COYA filings.
Frequently asked questions
What did COYA just say?
COYA cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are COYA SEC filings?
4 cached filings are on this page. EDGAR remains the official archive (CIK 0001835022).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.